Oct. 2 at 11:05 AM
Canaccord Genuity yesterday reiterated
$AXGN at a Buy rating and a
$24 price target.
$XBI $IBB
Canaccord Genuity today reiterated AxoGen, Inc. (AXGN) at a Buy rating and
$24 price target.
Canaccord Genuity's note from y'day also answers some questions y'all may have on the Shutdown in regards to the HHS/FDA and what in means to the Healthcare Industry.
Canaccord Genuity said in its notes to investors: